InvestSMART

ORDINARY FULLY PAID (ASX: OPT) - Announcements

DELISTED - Current share price for OPT : $0.013

ASX company news and announcements for ORDINARY FULLY PAID (OPT) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All ORDINARY FULLY PAID (OPT) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than ORDINARY FULLY PAID (OPT), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for ORDINARY FULLY PAID (OPT)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$18 Opthea to Host Investor Teleconference 9 Jun 2020 10:09AM $3.360 $0.013 fallen by 99.61%
$18 Trading Halt 9 Jun 2020 8:50AM $3.360 $0.013 fallen by 99.61%
$18 Change in substantial holding 2 Jun 2020 4:54PM $3.330 $0.013 fallen by 99.61%
$18 Change in substantial holding 5 May 2020 5:50PM $2.580 $0.013 fallen by 99.50%
$18 Change in substantial holding 16 Apr 2020 5:14PM $2.310 $0.013 fallen by 99.44%
$18 Becoming a substantial holder 31 Mar 2020 8:16AM $1.730 $0.013 fallen by 99.25%
$18 Opthea Completes Patient Dosing in Phase 2a DME Trial 30 Mar 2020 8:28AM $1.805 $0.013 fallen by 99.28%
$18 Ceasing to be a substantial holder from MUFG 26 Mar 2020 8:05PM $1.760 $0.013 fallen by 99.26%
$18 Ceasing to be a substantial holder from MS 26 Mar 2020 5:22PM $1.760 $0.013 fallen by 99.26%
$18 Becoming a substantial holder from MUFG 24 Mar 2020 7:02PM $1.555 $0.013 fallen by 99.16%
$18 Becoming a substantial holder from MS 24 Mar 2020 12:57PM $1.408 $0.013 fallen by 99.08%
$18 Ceasing to be a substantial holder 18 Mar 2020 8:01PM $1.645 $0.013 fallen by 99.21%
$18 Change in substantial holding 18 Mar 2020 5:36PM $1.645 $0.013 fallen by 99.21%
$18 Becoming a substantial holder 13 Mar 2020 8:28PM $2.280 $0.013 fallen by 99.43%
$18 Opthea Half Year Report and Accounts 26 Feb 2020 8:21AM $3.260 $0.013 fallen by 99.60%
$18 Opthea to Present at SVB Leerink Healthcare Conference 17 Feb 2020 8:52AM $3.400 $0.013 fallen by 99.62%
$18 Ceasing to be a substantial holder 16 Jan 2020 5:34PM $3.550 $0.013 fallen by 99.63%
$18 Becoming a substantial holder 9 Jan 2020 7:05PM $2.920 $0.013 fallen by 99.55%
$18 Opthea Completes Recruitment in Ph2a Trial of OPT-302 in DME 7 Jan 2020 8:38AM $2.930 $0.013 fallen by 99.56%
$18 Ceasing to be a substantial holder 16 Dec 2019 2:52PM $2.750 $0.013 fallen by 99.53%
$18 Becoming a substantial holder 12 Dec 2019 2:33PM $2.700 $0.013 fallen by 99.52%
$18 Change in substantial holding 10 Dec 2019 4:58PM $2.700 $0.013 fallen by 99.52%
$18 Ceasing to be a substantial holder 10 Dec 2019 4:48PM $2.700 $0.013 fallen by 99.52%
$18 Completion of A$50 million Institutional Placement 6 Dec 2019 9:42AM $3.030 $0.013 fallen by 99.57%
$18 Becoming a substantial holder 5 Dec 2019 5:46PM $3.030 $0.013 fallen by 99.57%

526 - 550 of 733 results

Page 22 of 30

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.